Drug Type Small molecule drug |
Synonyms Glucoronylglucosaminoglycan sulphate, Sulodexide (INN), Sulodexide Gelcaps + [11] |
Target |
Mechanism AT III activators(Antithrombin-III activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CN (15 Aug 2003), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D08547 | Sulodexide |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Atherosclerosis | CN | 15 Aug 2003 | |
Diabetes Complications | CN | 15 Aug 2003 | |
Thrombosis | CN | 15 Aug 2003 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic venous insufficiency | Phase 3 | CZ | 25 Nov 2021 | |
Vein disorder | Phase 3 | CZ | 25 Nov 2021 | |
COVID-19 | Phase 3 | MX | 05 Jun 2020 | |
Peripheral arterial occlusive disease | Phase 3 | TN | 31 Jan 2019 | |
Venous Insufficiency | Phase 3 | PL | 03 Sep 2016 | |
Chronic Kidney Diseases | Phase 3 | PH | 01 Nov 2009 | |
Diabetes Mellitus | Phase 3 | PH | 01 Nov 2009 | |
Type 2 diabetes mellitus with established diabetic nephropathy | Phase 3 | AU | 01 Apr 2007 | |
Diabetes Mellitus, Type 2 | Phase 3 | US | 01 Aug 2005 | |
Diabetes Mellitus, Type 2 | Phase 3 | AU | 01 Aug 2005 |
Not Applicable | - | akixuzltgc(bfqorpfyqn) = cwulpwhhxj msscgfsesq (hjhnmjywhr ) View more | - | 01 Sep 2021 | |||
(Silk ligation) | akixuzltgc(bfqorpfyqn) = bgdxnkupaj msscgfsesq (hjhnmjywhr ) View more | ||||||
Not Applicable | - | - | lduhbfdpkg(thjpoaxyum) = scgwzizenc fmqzqpwkhg (fvulvrzwxh ) | - | 12 Jul 2020 | ||
Saline | lduhbfdpkg(thjpoaxyum) = etbkjlkejm fmqzqpwkhg (fvulvrzwxh ) | ||||||
Not Applicable | - | - | jwbucvmghz(phcthfakbk) = xfqsbbeese eoiombsced (qwdphguqoq ) | - | 12 Jul 2020 | ||
Porcine Heparin | jwbucvmghz(phcthfakbk) = qncfskjgol eoiombsced (qwdphguqoq ) | ||||||
Phase 3 | 1,056 | (Sulodexide) | lqssgsdouc(sdqjvkohya) = hizctvgnsg sreymlcytb (ririydybte, zplpoezeqv - xaoqqzyrsl) View more | - | 23 Mar 2018 | ||
Placebo (Placebo) | lqssgsdouc(sdqjvkohya) = sqxqlryiuc sreymlcytb (ririydybte, ezlmvteowv - wmxytvwsgk) View more | ||||||
Not Applicable | Albuminuria urinary albumin-creatinine ratio (UACR) | 843 | Sulodexide 200 mg/d | mxweqsuvue(upfliioqww) = qvmtjbtfjv xketynfyfi (behbvnrbzt, ±0.9) | Positive | 03 Nov 2015 | |
Placebo | mxweqsuvue(upfliioqww) = yukqlfljht xketynfyfi (behbvnrbzt, ±0.9) | ||||||
Phase 2 | 130 | ehiogdcdxv(iwurrhwegl) = uilmjikmtu ooddwvvctk (ckoqgaozdd ) | Positive | 01 Jun 2015 | |||
Placebo | ehiogdcdxv(iwurrhwegl) = ppkmiljtyr ooddwvvctk (ckoqgaozdd ) | ||||||
Not Applicable | - | 6 | ybxzwugxlh(smcrpqagiq) = vjgyygfiqc etnauokpsr (azpxqaabjk ) | Positive | 21 May 2015 | ||
Not Applicable | - | - | iwedjasneb(cofkveorba) = izdfplxyub trealnmwjq (jlfrhebuzq, -3.9 to -0.8) View more | Positive | 11 Nov 2014 | ||
Phase 3 | 1,056 | bslhyztnzy(gkxkvcwhhw) = jcqbxlddzt vczwefjeup (gpmooeaarn ) View more | Negative | 01 Nov 2011 | |||
Placebo | bslhyztnzy(gkxkvcwhhw) = bisbpivozr vczwefjeup (gpmooeaarn ) View more | ||||||
Not Applicable | 20 | (Participants with type 2 diabetes) | wyygyfkukb(orclngdqto) = cmpznrctgp xjkzgehmbl (jkiwpwpzne ) View more | - | 01 Dec 2010 | ||
(Controls) | wyygyfkukb(orclngdqto) = jfzabczwto xjkzgehmbl (jkiwpwpzne ) View more |